Verified peer comparison
Emergent BioSolutions Inc. Common Stock vs iRhythm Financial Comparison
Emergent BioSolutions Inc. Common Stock versus iRhythm using 2025 financials in…
Direct answer
Emergent BioSolutions Inc. Common Stock and iRhythm are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Emergent BioSolutions Inc. Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Emergent BioSolutions Inc. Common Stock Revenue
- 742,900,000 USD
- iRhythm Revenue
- 747,138,000 USD
- Emergent BioSolutions Inc. Common Stock Operating income
- 110,200,000 USD
- iRhythm Operating income
- -36,810,000 USD